Skip to main content

Peer Review reports

From: General characteristics and reasons for the discontinuation of drug clinical trials in mainland China

Original Submission
15 Dec 2020 Submitted Original manuscript
14 May 2021 Reviewed Reviewer Report
21 Jul 2021 Reviewed Reviewer Report
31 Aug 2021 Author responded Author comments - Ben-nian Huo
Resubmission - Version 2
31 Aug 2021 Submitted Manuscript version 2
17 Sep 2021 Reviewed Reviewer Report
3 Oct 2021 Reviewed Reviewer Report
11 Oct 2021 Author responded Author comments - Ben-nian Huo
Resubmission - Version 3
11 Oct 2021 Submitted Manuscript version 3
Publishing
22 Oct 2021 Editorially accepted
13 Nov 2021 Article published 10.1186/s12874-021-01443-2

You can find further information about peer review here.

Back to article page